{
    "clinical_study": {
        "@rank": "38355", 
        "arm_group": [
            {
                "arm_group_label": "Intraperitoneal (IP) group", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive 100 ml of 0.2% Lignocaine as intraperitoneal lignocaine irrigation in the gall bladder fossa along with a placebo of normal saline of volume equivalent to 1.5 mg/kg of intravenous lignocaine at induction and normal saline of volume equivalent to 2 mg/kg/hour of intravenous lignocaine as continuous infusion until one hour postoperatively to ensure blinding"
            }, 
            {
                "arm_group_label": "Intravenous (IV) group", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive 1.5mg/kg of intravenous lignocaine as bolus dose at induction and 2mg/kg/hour as continuous infusion of intravenous lignocaine until one hour after surgery and 100 ml of saline intraperitoneally as placebo to ensure blinding."
            }
        ], 
        "brief_summary": {
            "textblock": "Laparoscopic Cholecystectomy is the treatment of choice for patients with symptomatic gall\n      stones. For pain relief following laparoscopic cholecystectomy both intraperitoneal and\n      intravenous administration of lignocaine has been used. But it is not clear from the\n      existing literature which form of administration is more effective for pain relief. Hence\n      this study has been undertaken with the following hypothesis : Intravenous lignocaine is\n      superior to intraperitoneal lignocaine for postoperative pain relief and minimizing the\n      stress response in laparoscopic cholecystectomy."
        }, 
        "brief_title": "Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Pain, Postoperative", 
            "Analgesic Requirement", 
            "Stress Response", 
            "Return of Bowel Activity", 
            "Inadequate or Impaired Respiratory Function"
        ], 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "Laparoscopic Cholecystectomy is the treatment of choice for patients with symptomatic gall\n      stones. For pain relief following laparoscopic cholecystectomy both intraperitoneal and\n      intravenous administration of lignocaine has been used. But it is not clear from the\n      existing literature which form of administration is more effective for pain relief. Hence\n      this study has been undertaken with the following hypothesis : Intravenous lignocaine is\n      superior to intraperitoneal lignocaine for postoperative pain relief and minimizing the\n      stress response in laparoscopic cholecystectomy.\n\n      In this study the effect of intraperitoneal and intravenous lignocaine will be assessed\n      based on the postoperative pain scores, total analgesic requirement, stress response in the\n      form of total leukocyte count, c-reactive protein levels,return of bowel activity."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients planned for elective laparoscopic cholecystectomy in the age group of 20 -60\n             years belonging to American society of anesthesiologists (ASA)score I-II\n\n        Exclusion Criteria:\n\n          -  Chronic pain diseases other than gall stone disease.\n\n          -  Use of opioids, steroids, Non steroidal anti inflammatory drugs or alcohol.\n\n          -  Allergy and contraindication to Lignocaine.\n\n          -  Conversion to open cholecystectomy.\n\n          -  Patients who do not comprehend Visual analogue scale (VAS) / patient controlled\n             analgesia (PCA)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01717222", 
            "org_study_id": "SEC/2011/4/109"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intraperitoneal (IP) group", 
                "description": "Patients will receive 100 ml of 0.2% lignocaine", 
                "intervention_name": "Intraperitoneal Lignocaine", 
                "intervention_type": "Drug", 
                "other_name": "IP Lignocaine"
            }, 
            {
                "arm_group_label": "Intravenous (IV) group", 
                "description": "Intravenous group patients will receive 1.5mg/kg of lignocaine as bolus dose at induction and 2mg/kg/hour as continuous infusion until one hour after surgery", 
                "intervention_name": "Intravenous Lignocaine", 
                "intervention_type": "Drug", 
                "other_name": "IV lignocaine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Lidocaine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Lignocaine", 
            "Laparoscopic cholecystectomy", 
            "Pain relief"
        ], 
        "lastchanged_date": "October 29, 2012", 
        "link": {
            "description": "Pubmed site", 
            "url": "http://www.ncbi.nlm.nih.gov"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Pondicherry", 
                    "country": "India", 
                    "zip": "605006"
                }, 
                "name": "Department of Surgery, JIPMER"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy - A Randomized Clinical Trial", 
        "other_outcome": [
            {
                "description": "Blood will be analyzed for TLC and CRP preoperatively and 48 hours postoperatively   to assess the stress response", 
                "measure": "Stress response in the form of Total Leucocyte Count (TLC) and C- reactive protein (CRP)", 
                "safety_issue": "No", 
                "time_frame": "Preoperatively and 48 hours Postoperatively"
            }, 
            {
                "description": "Respiratory function will be assessed by measuring the peak expiratory flow rate (PEFR)at the above mentioned time frames.", 
                "measure": "Respiratory Function", 
                "safety_issue": "No", 
                "time_frame": "Preoperatively and 48 hours Postoperatively"
            }, 
            {
                "description": "This will be assessed by asking the time at which the patient perceives the first bowel movement and also the time for passage of flatus post surgery.", 
                "measure": "Return of bowel activity", 
                "safety_issue": "No", 
                "time_frame": "upto to 48 hours"
            }
        ], 
        "overall_official": {
            "affiliation": "Jawaharlal Institute of Postgraduate Medical Education & Research", 
            "last_name": "Dr. Sarath Chandra Sistla, M.S.,", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Post operative pain relief will be assessed by visual analogue scale with values between 0 and 10. 0 denotes no pain and 10 denotes worst pain. the patient uses this scale to represent his/her pain at 1 hour postoperatively.", 
            "measure": "Post operative pain relief", 
            "safety_issue": "No", 
            "time_frame": "1 hour postoperatively"
        }, 
        "reference": {
            "PMID": "16121879", 
            "citation": "Jabbour-Khoury SI, Dabbous AS, Gerges FJ, Azar MS, Ayoub CM, Khoury GS. Intraperitoneal and intravenous routes for pain relief in laparoscopic cholecystectomy. JSLS. 2005 Jul-Sep;9(3):316-21."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01717222"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Jawaharlal Institute of Postgraduate Medical Education & Research", 
            "investigator_full_name": "Dr.D.Ram", 
            "investigator_title": "Junior Resident", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Patients will get analgesia through patient controlled analgesia pump (PCA). This pump delivers Morphine for pain relief. This will be delivered at 1 mg/ml bolus dose with a lock out period of 15 minutes without any background infusion of the drug. The total requirement over a period of 24 hours will be noted. Also the time taken for the patient to take the first analgesic dose will be recorded. The total demands and the number of good demands in the PCA pump will also be recorded.", 
                "measure": "Postoperative Analgesic Requirement", 
                "safety_issue": "No", 
                "time_frame": "First 24 hours in the postoperative period"
            }, 
            {
                "description": "Post operative pain relief will be assessed by visual analogue scale with values between 0 and 10. 0 denotes no pain and 10 denotes worst pain. the patient uses this scale to represent his/her pain at 8 hours postoperatively", 
                "measure": "Postoperative pain relief", 
                "safety_issue": "No", 
                "time_frame": "8 hours postoperatively"
            }, 
            {
                "description": "Post operative pain relief will be assessed by visual analogue scale with values between 0 and 10. 0 denotes no pain and 10 denotes worst pain. the patient uses this scale to represent his/her pain at 24 hours postoperatively", 
                "measure": "Postoperative pain relief", 
                "safety_issue": "No", 
                "time_frame": "24 hours postoperatively"
            }, 
            {
                "description": "Post operative pain relief will be assessed by visual analogue scale with values between 0 and 10. 0 denotes no pain and 10 denotes worst pain. the patient uses this scale to represent his/her pain at 48 hours postoperatively", 
                "measure": "Postoperative pain relief", 
                "safety_issue": "No", 
                "time_frame": "48 hours postoperatively"
            }
        ], 
        "source": "Jawaharlal Institute of Postgraduate Medical Education & Research", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jawaharlal Institute of Postgraduate Medical Education & Research", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}